Business Responsibility and Sustainability Report along with Assurance Report for the Financial Year 2025-26.

Date: August 21, 2026 Ref:- GHL/2026-27/EXCH/44 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Business Responsibility and Sustainability Report for Financial Year 2025-26. Dear Sir(s), Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Company's Business Responsibility and Sustainability Report along with Reasonable Assurance Report, for the Financial Year 2025-26. Kindly take the above on record. Thanking you, Yours faithfully For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M.No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Business Responsibility & Sustainability Report Business Responsibility & Sustainability Report SECTION A: SECTION B: SECTION C: GENERAL MANAGEMENT PRINCIPLE-WISE DISCLOSURES AND PROCESS PERFORMANCE DISCLOSURES DISCLOSURES Businesses should conduct and Businesses should provide goods Businesses should respect and govern themselves with integrity and services in a manner that is promote the wellbeing of all and in a manner that is ethical, sustainable and safe employees, including those in transparent and accountable their value chains 01 02 03 Businesses should respect the Businesses should Businesses should respect and interests of and be responsive to all respect and promote make efforts to protect and its stakeholders human rights restore the environment 04 05 06 Businesses, when engaging in Businesses should promote Businesses should engage influencing public and regulatory inclusive growth and with and provide value policy, should do so in a manner equitable development to their consumers in a that is responsible and transparent responsible manner 07 08 09 Annual Report 2025 - 26 01 GLOBAL HEALTH LIMITED Growing With Purpose, Institutionalising Quality Care SECTION A: GENERAL DISCLOSURES Medanta, operated by Global Health Limited, runs a network of six multi-specialty tertiary care hospitals across Gurugram, Indore, Ranchi, Lucknow, Patna and Noida, delivering care across 30+ medical specialities through more than 2,300 doctors. This section sets out the Company’s corporate identity, business activities, operational footprint, workforce profile and holding/subsidiary structure, along with the grievance redressal mechanisms established for communities, investors, employees, customers and value chain partners, forming the foundation for its Business Responsibility and Sustainability disclosures. Key Highlights H 45,088.60 14,777 50.8 Million (12,600 permanent) % Turnover Total workforce Women in the permanent workforce Stakeholders Impacted: Linkage with Capitals Patients Employees Shareholders Financial Capital Human Capital Investors Suppliers/ Local Social and Manufactured and Analysts Vendors Communities Relationship Capital Capital UN SDG Linkage 02 Annual Report 2025 - 26 Business Responsibility & Sustainability Report I. Details of the listed entity 1 Corporate Identity Number (CIN) of the Listed Entity L85110DL2004PLC128319 2 Name of the Listed Entity GLOBAL HEALTH LIMITED 3 Year of Incorporation 2004 4 Registered Office Address MEDANTA-MEDICLINIC, E-18, DEFENCE COLONY, NEW DELHI 110024 5 Corporate Address “Medanta The Medicity”, Sector 38, Gurugram, Haryana 122001 6 Email Address compliance@medanta.org 7 Telephone 91 124 483 4060 8 Website https://www.medanta.org/ 9 Financial Year for which reporting is being done FY 2025-26 10 Name of the Stock Exchange(s) where shares are National Stock Exchange of India Limited (“NSE”) listed NSE Symbol: MEDANTA BSE Limited (“BSE”) BSE Code: 543654 11 Paid-up Capital 53,73,80,764/- divided into 26,86,90,382 Equity Shares of Rs. 2/- each 12 Name and contact details (telephone, email address) Rahul Ranjan - of the person who may be contacted in case of any Company Secretary & Compliance Officer queries on the BRSR report E-mail id- compliance@medanta.org Tel: +91 124 483 4060 13 Reporting boundary - Are the disclosures under Consolidated basis unless otherwise specified this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). 14 Name of assessment or assurance provider S G S India private Limited 15 Type of assessment or assurance obtained BRSR Core Indicator - Reasonable Assurance and Limited Assurance of selected indicators for BRSR (other than core) II. Products/Services 16. Details of business activities (accounting for 90% of the turnover) S. Description of % of Turnover of Description of Business Activity No. Main Activity the Entity 1. Hospital and Global Health Limited (the “Company”) is one of the largest private 100% Medical Care multi-specialty tertiary care providers operating in the North and East regions of India, with key specialities in cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited. Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.6 millions sq. ft., its operational hospitals have 3,665 installed beds as on March 31, 2026. The Company provides healthcare services in over 30 medical specialties and engages over 2,400+ doctors led by highly experienced department heads. 17. Products/Services sold by the Entity (accounting for 90% of the Entity’s turnover) S. No. Product/Service NIC Code % of total Turnover contributed 1 Hospital and Medical Care 861 100% Annual Report 2025 - 26 03 GLOBAL HEALTH LIMITED Growing With Purpose, Institutionalising Quality Care III. Operations 18. Number of locations where plants and/or operations/offices of the Entity are situated: Location Number of plants Number of offices Total National 35* 2 37 International 0 0 0 *Includes 12 Retail Pharmacy, 9 Labs, 6 Hospital and 8 Clinic. 19. Markets served by the Entity a. Number of locations Location Number National (No. of States) 6 International (No. of Countries) 0* *Medanta renders services to international patients who travel to their facilities in India. b. What is the contribution of exports as a percentage of the total turnover of the Entity? The contribution of exports as a percentage of the total turnover of the entity is 5.22%. c. A brief on Types of customers Medanta caters to a diverse and extensive patient base, comprising both domestic and international patients seeking high-quality healthcare services. This broad patient mix reflects the Company’s strong clinical capabilities, established reputation for medical excellence, and ability to address a wide spectrum of healthcare needs across geographies and patient segments. IV. Employees 20. Details as at the end of Financial Year a. Employees and workers (including differently abled): S. Male Female Particulars Total (A) No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 12,600 6,200 49% 6,400 51% 2. Other than Permanent (E) 2,177 1,400 64% 777 36% 3. Total employees (D + E) 14,777 7,600 51% 7,177 49% WORKERS 4. Permanent (F) 0 0 0 0 0 5. Other than Permanent (G) 0 0 0 0 0 6. Total workers (F + G) 0 0 0 0 0 Note: 1. ‘Permanent Employees’ includes all the full-time employees with an indeterminate period. 2. ‘Other than Permanent Employees’ include all employees with a fixed term employment contract, Retainer Doctors, Residents, DNB Students. 3. In addition to [Showing first 8,000 characters — download PDF for full document]